Cyclic di-AMP (c-di-AMP) is an essential secondary messenger regulating cellwall homeostasis andmyriads of physiological processes in several Gram-positive andmycobacteria, including human pathogens.Hence, c-di-AMP synthesizing enzymes (DACs) have become a promising antibacterial drug target. To overcome a scarcity of small molecule inhibitors of c-di-AMP synthesizing enzyme CdaA, a computer-aided design of a new compound that should block the enzyme has been performed. This has led to the identification of a molecule comprising two thiazole rings and showing inhibitory potential based on ITC measurements. Thiazole scaffold is a good pharmacophore nucleus known due to its various pharmaceutical applications. It is contained in more than 18 FDA-approved drugs as well as in dozens of experimental drugs. Hence, the designed inhibitor can serve as a potent lead compound for further development of inhibitor against CdaA.
CITATION STYLE
Neumann, P., Kloskowski, P., & Ficner, R. (2023). Computer-aided design of a cyclic di-AMP synthesizing enzyme CdaA inhibitor. MicroLife, 4. https://doi.org/10.1093/femsml/uqad021
Mendeley helps you to discover research relevant for your work.